SEARCH

SEARCH BY CITATION

References

  • 1
    Sorrentino, M. J. ( 2000) Cholesterol reduction to prevent CAD. What do the data show? Postgrad. Med. 108, 4042, 45–46, 49–52.
  • 2
    He, J., Gu, D., Reynolds, K., Wu, X., Muntner, P., et al. ( 2004) Serum total and liporotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China. Circulation 110, 405411.
  • 3
    Zhao, D. ( 2006) Epidemiology of blood lipid in China. Clin. Focus 21, 533538.
  • 4
    Weber, C. and Noels, H. ( 2011) Atherosclerosis: current pathogenesis and therapeutic options. Nat. Med. 17, 14101422.
  • 5
    Iwata, H. and Nagai, R. ( 2012) Novel immune signals and atherosclerosis. Curr. Atheroscler. Rep. 14, 484490.
  • 6
    Ragino, Y. I., Chernyavski, A. M., Polonskaya, Y. V., Volkov, A. M., and Kashtanova, E. V. ( 2012) Activity of the inflammatory process in different types of unstable atherosclerotic plaques. Bull. Exp. Biol. Med. 153, 186189.
  • 7
    Kim, J. H., Kang, Y. J., and Kim, H. S. ( 2009) IL-8/CXCL8 upregulates 12-lipoxygenase expression in vascular smooth muscle cells from spontaneously hypertensive rats. Immune Netw. 9, 106113.
  • 8
    Wu, D., Nishimura, N., Kuo, V., Fiehn, O., Shahbaz, S., et al. ( 2011) Activation of aryl hydrocarbon receptor induces vascular inflammation and promotes atherosclerosis in apolipoprotein E−/− mice. Arterioscler. Thromb. Vasc. Biol. 31, 12601267.
  • 9
    Gerszten, R. E., Garcia-Zepeda, E. A., Lim, Y. C., Yoshida, M., Ding, H. A., et al. ( 1999) MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398, 718723.
  • 10
    Weber, K. S., von Hundelshausen, P., Clark-Lewis, I., Weber, P. C., and Weber, C. ( 1999) Differential immobilization and hierarchical involvement of chemokines in monocyte arrest and transmigration on inflamed endothelium in shear flow. Eur. J. Immunol. 29, 700712.
  • 11
    Boekholdt, S. M., Peters, R. J., Hack, C. E., Day, N. E., Luben, R., et al. ( 2004) IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women. Arterioscler. Thromb. Vasc. Biol. 24, 15031508.
  • 12
    Wang, J. M, Sica, A., Peri, G., Walter, S., Padura, I. M., et al. ( 1991) Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells. Arterioscler. Thromb. 11, 11661174.
  • 13
    Yue, T. L., Wang, X., Sung, C. P., Olson, B., McKenna, P. J., et al. ( 1994) Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells. Circ. Res. 75, 17.
  • 14
    Holmes, W. E., Lee, J., Kuang, W. J., Rice, G. C., and Wood, W. I. ( 1991) Structure and functional expression of a human interleukin-8 receptor. Science 253, 12781280.
  • 15
    Murphy, P. M. and Tiffany, H. L. ( 1991) Cloning of a complimentary DNA encoding a functional human interleukin-8 receptor. Science 253, 12801283.
  • 16
    Lee, Y. S., Choi, I., Ning, Y., Kim, N. Y., Khatchadourian, V., et al. ( 2012) Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis. Br. J. Cancer 106, 18331841.
  • 17
    Bischoff, D. S., Sakamoto, T., Ishida, K., Makhijani, N. S., Gruber, H. E., et al. ( 2011) CXC receptor knockout mice: characterization of skeletal features and membranous bone healing in the adult mouse. Bone 48, 267274.
  • 18
    Schuh, J. M., Blease, K., and Hogaboam, C. M. ( 2002) CXCR2 is necessary for the development and persistence of chronic fungal asthma in mice. J. Immunol. 168, 14471456.
  • 19
    Cunha, T. M., Barsante, M. M., Guerrero, A. T., Verri, W. A.Jr, Ferreira, S. H., et al. ( 2008) Treatment with DF 2162, a non-competitive allosteric inhibitor of CXCR1/2, diminishes neutrophil influx and inflammatory hypernociception in mice. Br. J. Pharmacol. 154, 460470.
  • 20
    Zhao, X., Town, J. R., Li, F., Zhang, X., Cockcroft, D. W., et al. ( 2009) ELR-CXC chemokine receptor antagonism targets inflammatory responses at multiple levels. J. Immunol. 182, 32133222.
  • 21
    Li, F., Zhang, X., and Gordon, J. R. ( 2002) CXCL8((3-73))K11R/G31P antagonizes ligand binding to the neutrophil CXCR1 and CXCR2 receptors and cellular responses to CXCL8/IL-8. Biochem. Biophys. Res. Commun. 293, 939944.
  • 22
    Li, F., Zhang, X., Mizzi, C., and Gordon, J. R. ( 2002) CXCL8((3-73))K11R/G31P antagonizes the neutrophil chemoattractants present in pasteurellosis and mastitis lesions and abrogates neutrophil influx inti intradermal endotoxin chanllenge sites in vivo. Vet. Immunol. Immunopathol. 90, 6577.
  • 23
    Kimes, B. W. and Brandt, B. L. ( 1976) Characterization of two putative smooth muscle cell lines from rat thoracic aorta. Exp. Cell. Res. 98, 349366.
  • 24
    Kishi, H., Mikawa, T., Seto M., Sasaki, Y., Kanayasu-Toyoda, T., et al. ( 2000) Stable transfectants of smooth muscle cell line lacking the expression of myosin light chain kinase and their characterization with respect to the actomyosin system. J. Biol. Chem. 275, 14141420.
  • 25
    Zhang, Y., Yu, G., Xiang, Y., Wu, J., Jiang, P., et al. ( 2010) Bm-TFF2, a toad trefoil factor, promotes cell migration, survival and wound healing. Biochem. Biophys. Res. Commun. 398, 559564.
  • 26
    Wick, G., Knoflach, M., and Xu, Q. ( 2004) Autoimmune and inflammatory mechanisms in atherosclerosis. Annu. Rev. Immunol. 22, 361403.
  • 27
    Libby, P., Okamoto, Y., Rocha, V. Z., and Folco, E. ( 2010) Inflammation in atherosclerosis: transition from theory to practice. Circ. J. 74, 213220.
  • 28
    Ridker, P. M. and Silvertown, J. D. ( 2008) Inflammation, C-reactive protein, and atherothrombosis. J. Periodontol. 79, 15441551.
  • 29
    Orr, A. W., Hastings, N. E., Blackman, B. R., and Wamhoff, B. R. ( 2010) Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis. J. Vasc. Res. 47, 168180.
  • 30
    Aukrust, P., Yndestad, A., Smith, C., Ueland, T., Gullestad, L., et al. ( 2007) Chemokines in cardiovascular risk prediction. Thromb. Haemost. 97, 748754.
  • 31
    Boekholdt, S. M., Peters, R. J., Hack, C. E., Day, N. E., Luben, R., et al. ( 2004) IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Arterioscler. Thromb. Vasc. Biol. 24, 15031508.
  • 32
    Aukrust, P., Yndestad, A., Smith, C., Ueland, T., Gullestad, L., et al. ( 2007) Chemokines in cardiovascular risk prediction. Thromb. Haemost. 97, 748754.
  • 33
    Herder, C., Baumert, J., Thorand, B., Martin, S., Löwel, H., et al. ( 2006) Chemokines and incident coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984–2002. Arterioscler. Thromb. Vasc. Biol. 26, 21472152.
  • 34
    Wu, D., Nishimura, N., Kuo, V., Fiehn, O., Shahbaz, S., et al. ( 2011) Activation of aryl hydrocarbon receptor induces vascular inflammation and promotes atherosclerosis in apolipoprotein E−/− mice. Arterioscler Thromb Vasc Biol. 31, 12601267.
  • 35
    Bhaskar, V., Yin, J., Mirza, A. M., Phan, D., Vanegas, S., et al. ( 2011) Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in apolipoprotein E-deficient mice. Atherosclerosis 216, 31320.
  • 36
    Zhang, T., Kurita-Ochiai, T., Hashizume, T., Du, Y., Oguchi, S., et al. ( 2010) Aggregatibacter actinomycetemcomitans accelerates atherosclerosis with an increase in atherogenic factors in spontaneously hyperlipidemic mice. FEMS Immunol. Med. Microbiol. 59, 143151.
  • 37
    Gotsman, I., Stabholz, A., Planer, D., Pugatsch, T., Lapidus, L., et al. ( 2008) Serum cytokine tumor necrosis factor-alpha and interleukin-6 associated with the severity of coronary artery disease: indicators of an active inflammatory burden? Isr. Med. Assoc. J. 10, 494498.
  • 38
    Liu, P., Xu, B., Cavalieri, T. A., and Hock, C. E. ( 2004) Attenuation of antioxidative capacity enhances reperfusion injury in aged rat myocardium after MI/R. Am. J. Physiol. Heart. Circ. Physiol. 287, H27192727.
  • 39
    Raines, E. W. and Ross, R. ( 1993) Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br. Heart. J. 69, S3037.
  • 40
    Van Hinsbergh, V. W. and Koolwijk, P. ( 2008) Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead. Cardiovasc. Res. 78, 203212.
  • 41
    Newby, A. C. ( 2007) Metalloproteinases and vulnerable atherosclerotic plaquesi. Trends Cardiovasc. Med. 17, 253258.
  • 42
    Newby, A. C. ( 2008) Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability. Arterioscler. Thromb. Vasc. Biol. 28, 21082114.
  • 43
    Jovanovic, M., Stefanoska, I., Radojcic, L., and Vicovac, L. ( 2010) Interleukin-8(CXCL8) stimulates trophoblast cell migration and invasion by increasing levels of matrix metalloproteinase (MMP)2 and MMP9 and integrins alpha5 and beta1. Reproduction 139, 789978.